Skip to main content

Table 6 Association between the TyG index and CAD severity in different glucose metabolic states

From: Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states

Glucose metabolic state

Multi-vessel coronary artery disease

Model 1

Model 2

Model 3

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

NGR

 TyG index

1.764 (0.944–3.295)

0.075

1.873 (0.970–3.617)

0.062

2.105 (0.906–4.893)

0.084

  T1

Reference

 

Reference

 

Reference

 

  T2

1.345 (0.562–3.217)

0.506

1.334 (0.522–3.409)

0.547

1.665 (0.571–4.859)

0.350

  T3

1.548 (0.646–3.707)

0.327

1.397 (0.559–3.490)

0.474

1.653 (0.529–5.160)

0.387

  T4

2.222 (0.892–5.534)

0.086

2.515 (0.948–6.670)

0.064

3.215 (0.943–10.967)

0.062

  P-trend

0.083

0.066

0.073

Pre-DM

 TyG index

1.231 (0.672–2.254)

0.502

1.279 (0.680–2.406)

0.445

0.741 (0.345–1.591)

0.442

  T1

Reference

 

Reference

 

Reference

 

  T2

2.095 (0.725–6.059)

0.172

2.165 (0.739–6.348)

0.159

2.286 (0.602–8.677)

0.225

  T3

1.481 (0.540–4.062)

0.445

1.449 (0.520–4.035)

0.478

0.789 (0.221–2.815)

0.715

  T4

0.821 (0.315–2.139)

0.686

0.856 (0.313–2.341)

0.761

0.347 (0.098–1.231)

0.101

  P-trend

0.481

0.124

0.048

DM

 TyG index

1.007 (0.603–1.682)

0.977

1.190 (0.661–2.144)

0.562

1.036 (0.948–1.132)

0.430

  T1

Reference

 

Reference

 

Reference

 

  T2

0.947 (0.319–2.812)

0.922

0.958 (0.311–2.951)

0.940

0.871 (0.201–3.766)

0.853

  T3

1.447 (0.475–4.410)

0.515

1.940 (0.593–6.345)

0.273

2.603 (0.581–11.676)

0.211

  T4

0.842 (0.280–2.530)

0.760

1.166 (0.344–3.955)

0.805

0.951 (0.192–4.700)

0.951

  P-trend

0.904

0.627

0.857

  1. Model 1: unadjusted
  2. Model 2: adjusted for age and sex
  3. Model 3: adjusted for age, sex, SBP, BMI, smoking status, drinking status, HDL-C, LDL-C, hypertension, status of antihypertensive drugs, status of antidiabetic drugs, status of antilipidemic drugs, status of antiplatelet drugs
  4. TyG index triglyceride-glucose index, CAD coronary artery disease, SBP systolic blood pressure, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol